General Information of the Compound
| Compound ID |
CP0058638
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-Amino-9-(4-hydroxy-3-hydroxymethyl-butyl)-1,9-dihydro-purin-6-one
Show/Hide
|
||||||||||||||||||
| Synonyms |
39809-25-1
BRL 39123
BRL-39123
CCRIS 9213
Denavir
PE2
Penciceovir
Penciclovir
Penciclovir [USAN:INN:BAN]
Penciclovirum
Penciclovirum [INN-Latin]
Pencyclovir
UNII-359HUE8FJC
Vectavir
penciclovir
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C10H15N5O3
|
||||||||||||||||||
| Molecular Weight |
253.262
|
||||||||||||||||||
| Canonical SMILES |
Nc1nc2n(CCC(CO)CO)cnc2c(=O)[nH]1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C10H15N5O3/c11-10-13-8-7(9(18)14-10)12-5-15(8)2-1-6(3-16)4-17/h5-6,16-17H,1-4H2,(H3,11,13,14,18)
Show/Hide
|
||||||||||||||||||
| InChIKey |
JNTOCHDNEULJHD-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
39809-25-1
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound
Drug 1 ( Penciclovir )
| Drug Name | Penciclovir | ||
|---|---|---|---|
| Indication | |||
| Target(s) | |||